The firms said that the deal will provide access to Tempus' testing menu for healthcare providers at 800 cancer care locations that use Flatiron's OncoEMR platform.
Shanghai's first deal at the 7th China International Import Expo was sealed around 1:30pm on Tuesday and involved a procurement order worth US$50 million.